Vein External Support Trial
Not Applicable
Completed
- Conditions
- Coronary Heart Disease
- Interventions
- Device: Fluent (VGS Fluent external support device)
- Registration Number
- NCT01415245
- Lead Sponsor
- Vascular Graft Solutions Ltd.
- Brief Summary
Prospective, multi-center, randomized, controlled pilot study to demonstrate the safety and effectiveness of the VGS Fluent external support device, supporting saphenous vein grafts in patients with coronary heart disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patient scheduled for on-pump CABG on clinical grounds
- Vein grafts indicated for right and circumflex coronary arteries and LIMA indicated for the LAD on clinical grounds
- Native circumflex and right coronary arteries have at least one stenosis in each vessel> 75%
Primary
Exclusion Criteria
- Concomitant non-CABG cardiac procedure
- Prior peripheral vascular or cardiac surgery
- Emergency CABG surgery (cardiogenic shock, inotrophic pressure support, IABP)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Fluent (VGS Fluent external support device) Device applied to saphenous vein graft
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Harefield Hospital
🇬🇧Middlesex, United Kingdom
The John Radcliffe Hospital
🇬🇧Oxford, United Kingdom
Royal Brompton Hospital
🇬🇧London, United Kingdom